Spiriva Respimat 3.124 ug/1 (Tiotropium Bromide Inhalation Spray SPRAY, METERED) 3.124 ug/1

Spiriva Respimat 3.124 ug/1 is a tiotropium bromide inhalation spray designed for respiratory use. This metered spray is commonly used for maintaining bronchodilation in conditions like chronic obstructive pulmonary disease (COPD).

Strength

3.124 ug/1

Pack Size

1 CARTRIDGE in 1 CARTON (0597-0100-61) / 60 SPRAY, METERED in 1 CARTRIDGE

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Spiriva Respimat 3.124 ug/1 is primarily used for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles around the airways to improve breathing. This medication is not intended for immediate relief of sudden breathing problems.

Side Effects

Common effects of using Spiriva Respimat 3.124 ug/1 may include dry mouth, throat irritation, and cough. Some users might experience blurred vision or dizziness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Spiriva Respimat 3.124 ug/1 should be used as directed and stored properly to maintain its effectiveness. It is important to follow the instructions for inhalation to ensure the correct dosage. Patients with certain medical conditions, such as glaucoma or urinary retention, should use this medication with caution.

Avoid Interactions

Spiriva Respimat 3.124 ug/1 may interact with other medications, including anticholinergics and some eye drops. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication.

Frequently Asked Questions

Spiriva Respimat 3.124 ug/1 is used for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).

Follow the instructions provided with the medication for proper inhalation technique. Ensure the spray is used as directed for optimal results.

Common side effects may include dry mouth, throat irritation, and cough. Some users might experience blurred vision or dizziness.

Patients with glaucoma should use Spiriva Respimat 3.124 ug/1 with caution and consult their healthcare provider before use.

Spiriva Respimat 3.124 ug/1 may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.